Summary of NICE advice on OA assessment and treatment.
Sarilumab (Kevzara) is a new biologic treatment for...
NICE has approved use of the JAK inhibitor baricitinib...
Register or Subscribe to MIMSGPs can get MIMS print & online and GPonline for free when they register online – take 2 minutes, and make sure you get your free MIMS access! If you're not a GP, you can subscribe to MIMS for full access.
Read the latest issue online exclusively on MIMS Learning.
Especially created for prescribing influencers.